215 related articles for article (PubMed ID: 31306370)
1. Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic Cardiomyopathy.
Maayah ZH; McGinn E; Al Batran R; Gopal K; Ussher JR; El-Kadi AOS
J Cardiovasc Pharmacol; 2019 Sep; 74(3):235-245. PubMed ID: 31306370
[TBL] [Abstract][Full Text] [Related]
2. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart.
Anwar-Mohamed A; El-Sherbeni AA; Kim SH; Althurwi HN; Zordoky BN; El-Kadi AO
Xenobiotica; 2012 Dec; 42(12):1235-47. PubMed ID: 22680237
[TBL] [Abstract][Full Text] [Related]
3. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
[TBL] [Abstract][Full Text] [Related]
4. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
[TBL] [Abstract][Full Text] [Related]
5. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
[TBL] [Abstract][Full Text] [Related]
6. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.
Alsaad AM; Zordoky BN; El-Sherbeni AA; El-Kadi AO
Drug Metab Dispos; 2012 Nov; 40(11):2126-35. PubMed ID: 22867862
[TBL] [Abstract][Full Text] [Related]
7. Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-κB and MAPK signaling pathways.
Abdelhamid G; El-Kadi AO
Free Radic Biol Med; 2015 May; 82():1-12. PubMed ID: 25614461
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
Tang Q; Len Q; Liu Z; Wang W
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528
[TBL] [Abstract][Full Text] [Related]
9. Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice.
Ma B; Xiong X; Chen C; Li H; Xu X; Li X; Li R; Chen G; Dackor RT; Zeldin DC; Wang DW
Endocrinology; 2013 Aug; 154(8):2843-56. PubMed ID: 23696562
[TBL] [Abstract][Full Text] [Related]
10. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
Huang H; Weng J; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
[TBL] [Abstract][Full Text] [Related]
11. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
[TBL] [Abstract][Full Text] [Related]
12. CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators.
Shi Z; He Z; Wang DW
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744996
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid cytochrome P450 epoxygenase pathway.
Spector AA
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model.
Chen L; Fan C; Zhang Y; Bakri M; Dong H; Morisseau C; Maddipati KR; Luo P; Wang CY; Hammock BD; Wang MH
Prostaglandins Other Lipid Mediat; 2013; 104-105():42-8. PubMed ID: 23247129
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPK.
Luo Y; Wu MY; Deng BQ; Huang J; Hwang SH; Li MY; Zhou CY; Zhang QY; Yu HB; Zhao DK; Zhang G; Qin L; Peng A; Hammock BD; Liu JY
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5154-5159. PubMed ID: 30804206
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats.
Guglielmino K; Jackson K; Harris TR; Vu V; Dong H; Dutrow G; Evans JE; Graham J; Cummings BP; Havel PJ; Chiamvimonvat N; Despa S; Hammock BD; Despa F
Am J Physiol Heart Circ Physiol; 2012 Oct; 303(7):H853-62. PubMed ID: 22865388
[TBL] [Abstract][Full Text] [Related]
19. Cinacalcet as a surrogate therapy for diabetic cardiomyopathy in rats through AMPK-mediated promotion of mitochondrial and autophagic function.
Elrashidy RA; Ibrahim SE
Toxicol Appl Pharmacol; 2021 Jun; 421():115533. PubMed ID: 33848515
[TBL] [Abstract][Full Text] [Related]
20. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.
Chen G; Xu R; Wang Y; Wang P; Zhao G; Xu X; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E563-75. PubMed ID: 22739108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]